Clinical Trials Logo

Clinical Trial Summary

Schizophrenia is a common disorder with a lifetime prevalence of about 1%.Genetic studies strongly suggest a genetic component to the inheritance of schizophrenia. Structural neuroimaging studies have provided consistent evidence for brain abnormalities in schizophrenia. The timing of brain abnormalities in schizophrenia has not been determined yet.

The investigators hypothesize that brain structural changes can be detected in neonatal life. The investigators hypothesize that offspring of schizophrenic patients will have higher rates of brain structural changes in the neonatal period. The investigators propose to study early development of fetuses in offspring of patients with schizophrenia. The study is a multi-center prospective trial.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening


Related Conditions & MeSH terms

  • Foetal Differences Between Healthy and Schizophernic Parents

NCT number NCT01655472
Study type Interventional
Source Tel-Aviv Sourasky Medical Center
Contact Nivi Rotenberg, M.D
Phone 972-50-7744593
Email nivirot@gmail.com
Status Not yet recruiting
Phase N/A
Start date July 2012
Completion date July 2015